You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 241 Clinical outcomes of metastatic melanoma patients with liver metastases treated with anti-PD-1 monotherapy versus combination ipilimumab/nivolumab

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
241 Clinical outcomes of metastatic melanoma patients with liver metastases treated with anti-PD-1 monotherapy versus combination ipilimumab/nivolumab

 

Online download statistics by month:

Online download statistics by month: November 2020 to November 2024

AbstractFullPdf
Nov 2020142021
Dec 20202804
Jan 20213405
Feb 20211403
Mar 20213806
Apr 20215606
May 20213012
Jun 2021002
Jul 2021004
Aug 2021006
Sep 2021005
Oct 202130022
Nov 202142018
Dec 20213802
Jan 20222401
Feb 20222802
Mar 20223205
Apr 20225604
May 20225405
Jun 20223602
Jul 20222403
Aug 20225605
Sep 20224205
Oct 20225804
Nov 20226004
Dec 20226003
Jan 20235405
Feb 20238804
Mar 202313608
Apr 20239804
May 202312202
Jun 202310403
Jul 202324409
Aug 202312804
Sep 202317004
Oct 202310605
Nov 202315402
Dec 202313800
Jan 2024200
Feb 202411400
Mar 202421009
Apr 202414005
May 202410202
Jun 20248403
Jul 202411602
Aug 20246204
Sep 20246001
Oct 20248006
Nov 202410803
Total35750244